Long-term survival outcomes and quality of life of image-guided proton therapy for operable stage I non-small cell lung cancer: A phase 2 study

Author:

Nakajima KoichiroORCID,Oguri Masanosuke,Iwata HiromitsuORCID,Hattori Yukiko,Hashimoto ShingoORCID,Nomura Kento,Hayashi Kensuke,Toshito ToshiyukiORCID,Akita Kenji,Baba FumiyaORCID,Ogino Hiroyuki,Hiwatashi AkioORCID

Funder

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Reference34 articles.

1. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: non–small cell lung cancer, version 2.2024. https://www.nccn.org/home [accessed 7 March 2024].

2. Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery;Chang;Lancet Oncol,2021

3. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial;Saji;Lancet,2022

4. Particle Therapy Co-Operative Group. Facilities in Operation. https://ptcog.site/index.php/facilities-in-operation-public [accessed 31 March 2024].

5. Consensus statement on proton therapy in early-stage and locally advanced non-small cell lung cancer;Chang;Int J Radiat Oncol Biol Phys,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3